Stock

Windlas Biotech — MTF Book

WINDLAS · Windlas Biotech Limited
Health Technology

Daily Margin Trading Facility book for Windlas Biotech across NSE and BSE, from 20 Feb 2025. All figures in ₹ crore, derived from exchange public disclosures.

What is Windlas Biotech’s MTF book?

Windlas Biotech Limited (WINDLAS) has ₹31 crore funded under Margin Trading Facility across NSE and BSE as of 23 Oct 2026 — 0.02% of India’s MTF book, ranking #840. Over 1M (the last 30 trading days) the funded value has risen 5.7%, with the number of shares under margin up 4.5%.

Funded value
₹31 Cr
as of 23 Oct 2026
Rank in book
#840
412 days tracked
Share of book
0.02%
of the whole NSE + BSE book
Peak funded
₹34 Cr
on 28 Sep 2026
Largest single-day addition
+₹4 Cr
on 26 Mar 2025
Largest single-day unwind
−₹3 Cr
on 24 Feb 2025
Free-float market cap
₹661 Cr
full market cap ₹1,801 Cr · 36.7% free float · Small cap
MTF share of free float
4.36%
2.0× the median small cap · 5.1× the Health Technology median

Share of free float on margin, month by month

Shares under margin at each month-end as a share of free-float shares, using that month-end’s share count and the free-float filing public at the time. It counts shares, not value, so a price move does not move it by itself.

1.42%2.64%3.85%5.07%Feb 2025Oct 2026
View as table: share of free float on margin21 months
Month-end% of free float
23 Oct 20264.360%
30 Sep 20264.647%
31 Aug 20263.775%
31 Jul 20263.504%
30 Jun 20263.701%
29 May 20263.575%
30 Apr 20263.312%
30 Mar 20263.248%
27 Feb 20263.635%
30 Jan 20263.382%
31 Dec 20253.597%
28 Nov 20253.070%
31 Oct 20252.873%
30 Sep 20252.891%
29 Aug 20252.714%
31 Jul 20252.711%
30 Jun 20252.768%
30 May 20252.831%
30 Apr 20252.637%
28 Mar 20252.647%
28 Feb 20251.843%

Dated events

NSE & BSE split

How WINDLAS’s funded book divides across the two exchanges, as of 23 Oct 2026.
NSE
NSE ₹31 Cr · 98.1%BSE ₹1 Cr · 1.9%

MTF vs Price

Margin-funded outstanding for WINDLAS in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹872.70
as of 23 Oct 2026
Price, 1M
−23.6%
adjusted for splits and bonuses
Delivery, 20-day avg
47.8%
of traded volume actually settled
Sessions to unwind
8
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1D−₹1−2.2%−1.9%
−6,264
−3.1%unwinding as it falls
10D−₹2−5.4%−4.1%
−14,115
−12.0%unwinding as it falls
1M+₹2+5.7%+4.5%
+14,052
−23.9%building as it falls
3M+₹8+33.6%+21.7%
+58,896
+1.3%building into strength
6M+₹8+36.5%+24.3%
+64,574
−2.4%building as it falls
1Y+₹11+51.7%+45.0%
+1,02,525
−7.1%building as it falls

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where WINDLAS has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

WINDLAS — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
23 Oct 202631−₹10.02%840
22 Oct 202632+₹00.02%840
21 Oct 202632−₹00.02%844
19 Oct 202632−₹00.02%839
16 Oct 202633−₹00.02%840
15 Oct 202633−₹00.02%840
14 Oct 202633+₹00.02%838
13 Oct 202633−₹00.02%839
12 Oct 202633+₹00.02%835
09 Oct 202633−₹00.02%838
08 Oct 202633−₹00.02%838
07 Oct 202634−₹00.02%828
06 Oct 202634−₹00.02%825
05 Oct 202634+₹10.02%822
01 Oct 202633−₹10.02%825
30 Sep 202634−₹00.02%821
29 Sep 202634−₹00.02%823
28 Sep 202634+₹10.02%821
25 Sep 202634+₹00.02%832
24 Sep 202633+₹00.02%838
23 Sep 202633+₹10.02%839
22 Sep 202632+₹00.02%846
21 Sep 202632−₹00.02%844
18 Sep 202632+₹00.02%835
17 Sep 202632+₹10.02%842
16 Sep 202631+₹00.02%850
15 Sep 202631+₹00.02%852
11 Sep 202631+₹00.02%860
10 Sep 202631+₹00.02%861
09 Sep 202631—0.02%864

WINDLAS within Health Technology

Ranked #51 of 61 funded Health Technology stocks, carrying 0.5% of that sector’s margin book. Its 4.36% of free float on margin is 4.8× the sector median of 0.90%. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector% of free floatBook, 1M
49INDGNIndegene₹340.5%0.24%−23.7%
50SAIPARENTSai Parenterals₹320.5%2.81%+18.2%
51WINDLASWindlas Biotech₹310.5%4.36%+5.7%
52AARTIDRUGSAarti Drugs₹310.5%1.73%+1.3%
53ALKEMAlkem Laboratories₹280.4%0.09%−13.1%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.